---
title: News
date: 2024-01-05 08:01:35 +0300
label: 
image: '/images/newspage.png'
featured:
---

<details>
  <summary style="font-size: 24px;">2024</summary>
  
  <ul>
    <li style="font-size: 18px;">February 2024-We published “SLIDE: Significant Latent factor Interaction Discovery and Exploration across biological domains” in Nature Methods.</li>
  </ul>
</details>

<details>
  <summary style="font-size: 24px;">2023</summary>
  
  <ul>
    <li style="font-size: 18px;">December 2023-We published “From bench to bedside via bytes: multi-omic immunoprofiling and integration using machine learning and network approaches” in Human Vaccines and Immunotherapeutics.</li>
    <li style="font-size: 18px;">December 2023-We contributed to “PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition”, which was published in Cell Reports Medicine.</li>
    <li style="font-size: 18px;">November 2023-We contributed to “SARS-CoV2 mRNA vaccines induce greater complement activation and decreased viremia and Nef antibodies in men with HIV-1”,which was published in The Journal of Infectious Diseases.</li>
    <li style="font-size: 18px;">October 2023-Jishnu gave an invited talk at BMES 2023 on, "Elucidating humoral profiles associated with Schistosomiasis pathogenesis using interpretable machine learning".</li>
    <li style="font-size: 18px;">October 2023-Jishnu gave an invited talk at BMES 2023 on, "Significant latent factor interaction discovery and exploration across biological domains".</li>
    <li style="font-size: 18px;">August 2023-We published “Cell Type-Specific Biomarkers of Systemic Sclerosis Disease Severity Capture Cell-Intrinsic and Cell-Extrinsic Circuits” in Arthritis & Rheumatology.</li>
    <li style="font-size: 18px;">August 2023-We contributed to “Stability and heterogeneity in the antimicrobiota reactivity of human milk-derived immunoglobulin A”, which got published in the Journal of Experimental Medicine.</li>
    <li style="font-size: 18px;">July 2023-We contributed to “The gut protist Tritrichomonas arnold restrains virus-mediated loss of oral tolerance by modulating dietary antigen-presenting dendritic cells”, which got published in Immunity.</li>
    <li style="font-size: 18px;">June 2023-We published“Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associate with favorable outcomes in severe COVID-19" in Cell Reports.</li>
    <li style="font-size: 18px;">May 2023-Jishnu gave an invited talk at FASEB Autoimmunity 2023 on , "Multi-dimensional integration of protein interactomes with genomic and molecular data discover distinct RA endotypes".</li>
    <li style="font-size: 18px;">March 2023-Jishnu gave an invited talk at Cold Spring Harbor Laboratory Network Biology Meeting 2023 on "Uncovering immunomodulatory molecular phenotypes in infectious disease using networks".</li>
    <li style="font-size: 18px;">April 2023-Jishnu gave an invited talk at Cold Spring Harbor Laboratory Systems Immunology Meeting 2023 on "Multi-dimensional integration of protein interactomes with genomic and molecular data discovers distinct RA endotypes".</li>
    <li style="font-size: 18px;">April 2023-We contributed to “Antibodies against the Ebola virus soluble glycoprotein are associated with long-term vaccine-mediated protection of non-human primates”, which got published in the Cell Reports.</li>
    <li style="font-size: 18px;">February 2023-We contributed to “High-dimensional proteomics identifies organ injury patterns associated with outcomes in human trauma”, which got published in the The Journal of Trauma and Acute Care Surgery.</li>
  </ul>
</details>

<details>
  <summary style="font-size: 24px;">2022</summary>
  
  <ul>
    <li style="font-size: 18px;">October 2022-Jishnu is a Co-I at Systemic Sclerosis Center for Research and Translation which provides machine learning and network systems expertise to investigators working on SSc, SSc-ILD and SSc-PAH.</li>
    <li style="font-size: 18px;">October 2022-Jishnu is a Co-I on the U01 Grant funded to characterize cell-intrinsic and cell-extrinsic signaling circuits in ocular disorders.</li>
    <li style="font-size: 18px;">September 2022-Jishnu gave an invited talk at the Banff-CST Joint Transplant and Pathology Summit titled “Machine learning in clinical decision making in transplant biology”.</li>
    <li style="font-size: 18px;">August 2022-We published A supervised take on dimensionality reduction via hybrid subset selection in Patterns.</li>
    <li style="font-size: 18px;">August 2022-Jishnu gave a talk at International Workshop on Scleroderma 2022 in Boston.</li>
    <li style="font-size: 18px;">July 2022-Jishnu was invited to give a talk at ISMB 2022 on the topic “A network-based approach to identify expression modules underlying rejection in pediatric liver transplantation”.</li>
    <li style="font-size: 18px;">July 2022-Scleroderma CDMRO Award was given to Jishnu (role: Co-I).</li>
    <li style="font-size: 18px;">July 2022-The Philadelphia Enquirer covered our very recent publication on COVID-19.</li>
    <li style="font-size: 18px;">July 2022-Our work got covered in Pittsburgh's Action 4 News "4 Your Health: Studying COVID-19 antibody patterns".</li>
    <li style="font-size: 18px;">July 2022-Jishnu becomes a co-Director for the Systems Immunology Core (funded by NIAMS P50) which will perform machine learning and network systems analyses on multi-modal datasets in the context of SSc.</li>
    <li style="font-size: 18px;">June 2022-Our paper Multi-Omic Admission-Based Prognostic Biomarkers Identified by Machine Learning Algorithms Predict Patient Recovery and 30>Day Survival in Trauma Patients got accepted in Metabolites</li>
    <li style="font-size: 18px;">June 2022-Our paper High Dimensional Multi-omics Reveals Unique Characteristics of Early Plasma Administration in Polytrauma Patients with TBI got accepted in Annals of Surgery</li>
    <li style="font-size: 18px;">June 2022-We published Antibodies targeting conserved non-canonical antigens and endemic coronaviruses associated with favorable outcomes in severe COVID-19 in Cell Press.</li>
    <li style="font-size: 18px;">May 2022-We found out that our NIAID Flu Systems Vaccinology R01 (Role: MPI, other PIs: Alcorn, Singh, Zimmerman) will be funded.</li>
  </ul>
</details>

<details>
  <summary style="font-size: 24px;">2021</summary>
  
  <ul>
    <li style="font-size: 18px;">September 2021-A NIAID R01 we participated in (Role: co-I, PIs: Rinaldo and Mailliard) looking at COVID-19 vaccine responses in HIV individuals was funded.</li>
    <li style="font-size: 18px;">September 2021-We received a 5-year NHGRI U01 1U01HG012041-01 (Role: MPI, Other PIs: Singh, Sahni)- Link on NIH Reporter.</li>
    <li style="font-size: 18px;">August 2021-We received a 5-year NIAID New Innovator DP2 Award 1DP2AI164325-01 (Role: PI)- Link on NIH Reporter.</li>
    <li style="font-size: 18px;">June 2021-An NIDDK dkNET New Investigator Pilot Program in Bioinformatics grant that we participated in has been funded (Role: co-I, PI: Joglekar).</li>
    <li style="font-size: 18px;">June 2021-We contributed to Mechanisms of impaired lung development and ciliation in Mannosidase-1-alpha-2 (Man1a2) mutants in Frontiers in Physiology.</li>
    <li style="font-size: 18px;">April 2021-Jishnu gave a talk at the 2021 Cold Spring Harbor Systems Immunology Meeting.</li>
    <li style="font-size: 18px;">April 2021-A Department of Defense Idea Development Award grant that we participated in has been funded (Role: co-I, PI: Lafyatis).</li>
    <li style="font-size: 18px;">March 2021-Jishnu gave a talk at the 2021 Cold Spring Harbor Networks Meeting.</li>
  </ul>
</details>

<details>
  <summary style="font-size: 24px;">2020</summary>
  
  <ul>
    <li style="font-size: 18px;">October 2020-We published Mining for humoral correlates of HIV control and latent reservoir size in PLoS pathogens.</li>
    <li style="font-size: 18px;">September 2020-We contributed to Extracellular Matrix Injury of Kidney Allografts in Antibody-Mediated Rejection: A Proteomics Study, which was published in the Journal of the American Society of Nephrology.</li>
    <li style="font-size: 18px;">August 2020-We are now supported by a Collaborative Research Agreement with the University of Brussels Center for Research In Immunology (Role: PI)!</li>
    <li style="font-size: 18px;">July 2020-We contributed to Glucosylation by the Legionella effector SetA promotes the nuclear localization of the transcription factor TFEB, which was published in Science.</li>
    <li style="font-size: 18px;">July 2020-We published Mapping functional humoral correlates of protection against malaria challenge following RTS, S/AS01 vaccination in Science Translational Medicine.</li>
    <li style="font-size: 18px;">June 2020-We received a pilot Covid-19 grant from the UPMC-ITTC (Role: PI)!</li>
    <li style="font-size: 18px;">May 2020-We contributed to Co-immunization of DNA and Protein in the Same Anatomical Sites Induces Superior Protective Immune Responses against SHIV Challenge, which was published in Cell Reports.</li>
    <li style="font-size: 18px;">March 2020-We contributed to Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells, which was published in PLoS pathogens.</li>
    <li style="font-size: 18px;">March 2020-We contributed to Epigenetic basis for monocyte dysfunction in patients with severe alcoholic hepatitis, which was published in the Journal of Hepatology.</li>
    <li style="font-size: 18px;">February 2020-We published Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis in The Journal of Infectious Diseases.</li>
    <li style="font-size: 18px;">January 2020-The Das Systems Immunology Lab is now supported by Center for Systems Immunology Startup Funds!</li>
    <li style="font-size: 18px;">January 2020-The lab is now open! We look forward to exciting science in the future!</li>
  </ul>
</details>
